|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
7/3/19 Abvc Biopharma, Inc. 8-K:5,9 6/28/19 1:29K EdgarAgents LLC/FA
6/28/19 Abvc Biopharma, Inc. CORRESP¶ 9/5/19 1:37K EdgarAgents LLC/FA
6/28/19 Abvc Biopharma, Inc. S-1/A 8:9.7M EdgarAgents LLC/FA
____________ | ¹ | Filing/Form Types: -K | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | CORRESP | Comment-Response or Other Letter to the SEC. | | S-1 | Registration Statement (General Form) — Form S-1. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. | | ¶ | This Filing contains a delayed-release Document. |
|